247 related articles for article (PubMed ID: 11927627)
1. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection.
Sjölin H; Tomasello E; Mousavi-Jazi M; Bartolazzi A; Kärre K; Vivier E; Cerboni C
J Exp Med; 2002 Apr; 195(7):825-34. PubMed ID: 11927627
[TBL] [Abstract][Full Text] [Related]
2. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.
Tomasello E; Desmoulins PO; Chemin K; Guia S; Cremer H; Ortaldo J; Love P; Kaiserlian D; Vivier E
Immunity; 2000 Sep; 13(3):355-64. PubMed ID: 11021533
[TBL] [Abstract][Full Text] [Related]
3. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions.
Tomasello E; Vivier E
Eur J Immunol; 2005 Jun; 35(6):1670-7. PubMed ID: 15884055
[TBL] [Abstract][Full Text] [Related]
4. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.
Orr MT; Sun JC; Hesslein DG; Arase H; Phillips JH; Takai T; Lanier LL
J Exp Med; 2009 Apr; 206(4):807-17. PubMed ID: 19332875
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.
Snyder MR; Nakajima T; Leibson PJ; Weyand CM; Goronzy JJ
J Immunol; 2004 Sep; 173(6):3725-31. PubMed ID: 15356118
[TBL] [Abstract][Full Text] [Related]
6. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
[TBL] [Abstract][Full Text] [Related]
8. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
Jensen IJ; Winborn CS; Fosdick MG; Shao P; Tremblay MM; Shan Q; Tripathy SK; Snyder CM; Xue HH; Griffith TS; Houtman JC; Badovinac VP
PLoS Pathog; 2018 Oct; 14(10):e1007405. PubMed ID: 30379932
[TBL] [Abstract][Full Text] [Related]
9. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways.
Oberg L; Johansson S; Michaëlsson J; Tomasello E; Vivier E; Kärre K; Höglund P
Eur J Immunol; 2004 Jun; 34(6):1646-53. PubMed ID: 15162434
[TBL] [Abstract][Full Text] [Related]
10. Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice.
Lucas M; Daniel L; Tomasello E; Guia S; Horschowski N; Aoki N; Figarella-Branger D; Gomez S; Vivier E
Eur J Immunol; 2002 Sep; 32(9):2653-63. PubMed ID: 12207350
[TBL] [Abstract][Full Text] [Related]
11. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules.
Nochi H; Aoki N; Oikawa K; Yanai M; Takiyama Y; Atsuta Y; Kobayashi H; Sato K; Tateno M; Matsuno T; Katagiri M; Xing Z; Kimura S
Am J Pathol; 2003 Apr; 162(4):1191-201. PubMed ID: 12651611
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.
Snyder MR; Lucas M; Vivier E; Weyand CM; Goronzy JJ
J Exp Med; 2003 Feb; 197(4):437-49. PubMed ID: 12591902
[TBL] [Abstract][Full Text] [Related]
13. Multiplicity and plasticity of natural killer cell signaling pathways.
Chiesa S; Mingueneau M; Fuseri N; Malissen B; Raulet DH; Malissen M; Vivier E; Tomasello E
Blood; 2006 Mar; 107(6):2364-72. PubMed ID: 16291591
[TBL] [Abstract][Full Text] [Related]
14. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection.
Dorner BG; Smith HR; French AR; Kim S; Poursine-Laurent J; Beckman DL; Pingel JT; Kroczek RA; Yokoyama WM
J Immunol; 2004 Mar; 172(5):3119-31. PubMed ID: 14978118
[TBL] [Abstract][Full Text] [Related]
15. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.
Nataf S; Anginot A; Vuaillat C; Malaval L; Fodil N; Chereul E; Langlois JB; Dumontel C; Cavillon G; Confavreux C; Mazzorana M; Vico L; Belin MF; Vivier E; Tomasello E; Jurdic P
Am J Pathol; 2005 Jan; 166(1):275-86. PubMed ID: 15632019
[TBL] [Abstract][Full Text] [Related]
16. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
[TBL] [Abstract][Full Text] [Related]
17. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity.
Sumaria N; van Dommelen SL; Andoniou CE; Smyth MJ; Scalzo AA; Degli-Esposti MA
Immunol Cell Biol; 2009 Oct; 87(7):559-66. PubMed ID: 19564888
[TBL] [Abstract][Full Text] [Related]
18. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming.
Bakker AB; Hoek RM; Cerwenka A; Blom B; Lucian L; McNeil T; Murray R; Phillips LH; Sedgwick JD; Lanier LL
Immunity; 2000 Sep; 13(3):345-53. PubMed ID: 11021532
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice.
McVicar DW; Winkler-Pickett R; Taylor LS; Makrigiannis A; Bennett M; Anderson SK; Ortaldo JR
J Immunol; 2002 Aug; 169(4):1721-8. PubMed ID: 12165492
[TBL] [Abstract][Full Text] [Related]
20. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
Anfossi N; Lucas M; Diefenbach A; Bühring HJ; Raulet D; Tomasello E; Vivier E
Eur J Immunol; 2003 Dec; 33(12):3514-22. PubMed ID: 14635062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
